1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Marketing & Advertising

Amazon's Solimo Supplements' Prices, Selection Slow Market Share Incursion

 
• By Eileen Francis

Amazon’s Solimo supplements and personal care line overall is priced higher than Walgreens' brand but lower than CVS', Jefferies Equity Research Americas found. Solimo could present a formidable threat to the supplements category, but its limited assortment so far and pricing should prevent “material market share shifts” in the near-term, Jefferies says.

Amazon.com Inc.’s Solimo dietary supplement line's comparatively limited selection and generally higher prices are cooling its potential for grabbing market share, according to Jefferies Equity Research Americas.

Solimo’s lineup of around 30 supplement products and 100 personal care items launched in early 2018 is priced higher than...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

Get To Know: Healthy Aging Specialist Prime Fifty

 
• By David Ridley

Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.

Haleon Adds High Strength Vitamin D To UK Centrum Multivitamin Line

 
• By David Ridley

Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By David Ridley

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

OLLY’s Lovin’ Libido Claims Score Support With Studies Of Women Reporting ‘Generally Low’ Desire

 
• By Malcolm Spicer

NAD reports the populations of six of seven RCTs Olly referenced as evidence were key in substantiating claims for Lovin’ Libido ashwagandha supplement challenged by Bayer. Supplement industry, though, is challenging the FTC’s RCT standard for claims support.

More from Business

US Consumer Health Q2 Earnings Preview: Baggage Comes With Costs, Expectations

 
• By Malcolm Spicer

In addition to impact from tariffs and executive suite changes, recent baggage for firms in the space include Perrigo divesting its branded Dermacosmetics business and Church & Dwight acquiring Touchland hand sanitizer brand.

Expanded Distribution In US Helps Drive Up BioGaia Sales

 
• By Tom Gallen

Swedish probiotics player BioGaia is reaping the benefits of increased marketing investments and distribution in the US.

Change In P&G’s Helm Coming As Planning For Impact From Tariff Increases In Difficulty

 
• By Malcolm Spicer

Even as CEO Jon Moeller and lead board member Joe Jiminez as well as analysts state confidence the firm’s growth strategy will continue with the executive suite change, the impact of tariff policies could put a dent in its results.